C.I. MedicalLtd Future Growth
Future criteria checks 3/6
C.I. MedicalLtd is forecast to grow earnings and revenue by 18.3% and 11.3% per annum respectively. EPS is expected to grow by 18.3% per annum. Return on equity is forecast to be 13.5% in 3 years.
Key information
18.3%
Earnings growth rate
18.3%
EPS growth rate
| Healthcare earnings growth | 9.1% |
| Revenue growth rate | 11.3% |
| Future return on equity | 13.5% |
| Analyst coverage | Low |
| Last updated | 15 Mar 2024 |
Recent future growth updates
Recent updates
Here's Why We Think C.I. MedicalLtd (TYO:3540) Is Well Worth Watching
May 02
Returns on Capital Paint A Bright Future For C.I. MedicalLtd (TYO:3540)
Apr 14Should You Investigate C.I. Medical Co.,Ltd. (TYO:3540) At JP¥5,450?
Mar 08Introducing C.I. MedicalLtd (TYO:3540), The Stock That Zoomed 114% In The Last Year
Feb 18Should You Be Adding C.I. MedicalLtd (TYO:3540) To Your Watchlist Today?
Jan 31
Can C.I. MedicalLtd (TYO:3540) Keep Up These Impressive Returns?
Jan 13Could The Market Be Wrong About C.I. Medical Co.,Ltd. (TYO:3540) Given Its Attractive Financial Prospects?
Dec 26Is C.I. Medical Co.,Ltd. (TYO:3540) Potentially Undervalued?
Dec 08Can You Imagine How Jubilant C.I. MedicalLtd's (TYO:3540) Shareholders Feel About Its 118% Share Price Gain?
Nov 20The C.I. MedicalLtd (TYO:3540) Share Price Is Up 60% And Shareholders Are Holding On
Jul 07Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 64,000 | 3,600 | N/A | 3,430 | 1 |
| 12/31/2025 | 56,000 | 2,950 | N/A | 2,050 | 1 |
| 12/31/2024 | 50,000 | 2,430 | N/A | 247 | 1 |
| 12/31/2023 | 45,628 | 2,082 | -9,086 | -156 | N/A |
| 9/30/2023 | 45,071 | 2,162 | N/A | N/A | N/A |
| 6/30/2023 | 44,125 | 2,219 | -4,594 | 1,090 | N/A |
| 3/31/2023 | 43,473 | 2,173 | N/A | N/A | N/A |
| 12/31/2022 | 42,891 | 2,521 | -7,939 | 1,409 | N/A |
| 9/30/2022 | 42,073 | 2,709 | N/A | N/A | N/A |
| 6/30/2022 | 41,754 | 2,798 | -4,720 | 2,077 | N/A |
| 3/31/2022 | 41,142 | 2,815 | N/A | N/A | N/A |
| 12/31/2021 | 41,205 | 2,820 | -1,253 | 1,578 | N/A |
| 9/30/2021 | 41,500 | 3,182 | N/A | N/A | N/A |
| 6/30/2021 | 40,833 | 3,334 | 4,083 | 4,497 | N/A |
| 3/31/2021 | 39,593 | 3,309 | N/A | N/A | N/A |
| 12/31/2020 | 37,393 | 2,920 | 3,701 | 4,159 | N/A |
| 9/30/2020 | 33,251 | 2,263 | N/A | N/A | N/A |
| 6/30/2020 | 31,964 | 1,924 | 211 | 473 | N/A |
| 3/31/2020 | 30,265 | 1,608 | N/A | N/A | N/A |
| 12/31/2019 | 28,763 | 1,505 | 1,144 | 1,402 | N/A |
| 9/30/2019 | 28,876 | 1,571 | N/A | N/A | N/A |
| 6/30/2019 | 26,898 | 1,345 | 613 | 1,127 | N/A |
| 3/31/2019 | 26,484 | 1,414 | N/A | N/A | N/A |
| 12/31/2018 | 25,806 | 1,329 | 212 | 722 | N/A |
| 9/30/2018 | 24,892 | 1,358 | N/A | N/A | N/A |
| 6/30/2018 | 24,323 | 1,458 | 1,340 | 1,579 | N/A |
| 3/31/2018 | 23,336 | 1,445 | N/A | N/A | N/A |
| 12/31/2017 | 22,830 | 1,539 | 719 | 1,006 | N/A |
| 9/30/2017 | 21,999 | 1,486 | N/A | N/A | N/A |
| 6/30/2017 | 21,440 | 1,497 | N/A | 491 | N/A |
| 3/31/2017 | 20,887 | 1,390 | N/A | 781 | N/A |
| 12/31/2016 | 20,334 | 1,282 | N/A | 1,071 | N/A |
| 12/31/2015 | 18,145 | 1,088 | N/A | N/A | N/A |
| 12/31/2014 | 16,084 | 901 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 3540's forecast earnings growth (18.3% per year) is above the savings rate (0.2%).
Earnings vs Market: 3540's earnings (18.3% per year) are forecast to grow faster than the JP market (9.4% per year).
High Growth Earnings: 3540's earnings are forecast to grow, but not significantly.
Revenue vs Market: 3540's revenue (11.3% per year) is forecast to grow faster than the JP market (4.4% per year).
High Growth Revenue: 3540's revenue (11.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 3540's Return on Equity is forecast to be low in 3 years time (13.5%).